SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 134 filers reported holding SAGENT PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $54,000 | +58.8% | 3,604 | +27.6% | 0.00% | – |
| Q1 2016 | $34,000 | 0.0% | 2,824 | +30.8% | 0.00% | – |
| Q4 2015 | $34,000 | -19.0% | 2,159 | -21.5% | 0.00% | – |
| Q3 2015 | $42,000 | +110.0% | 2,751 | +239.6% | 0.00% | – |
| Q2 2015 | $20,000 | +33.3% | 810 | +28.8% | 0.00% | – |
| Q1 2015 | $15,000 | -6.2% | 629 | -0.5% | 0.00% | – |
| Q4 2014 | $16,000 | -30.4% | 632 | -13.7% | 0.00% | – |
| Q3 2014 | $23,000 | +15.0% | 732 | -3.6% | 0.00% | – |
| Q2 2014 | $20,000 | +66.7% | 759 | +42.1% | 0.00% | – |
| Q1 2014 | $12,000 | -14.3% | 534 | +0.2% | 0.00% | – |
| Q4 2013 | $14,000 | -46.2% | 533 | -57.6% | 0.00% | – |
| Q3 2013 | $26,000 | +85.7% | 1,257 | +87.6% | 0.00% | – |
| Q2 2013 | $14,000 | – | 670 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 462,824 | $7,364,000 | 8.63% |
| HealthCor Management, L.P. | 1,750,000 | $27,843,000 | 1.69% |
| ACUTA CAPITAL PARTNERS, LLC | 144,667 | $2,302,000 | 1.10% |
| THB ASSET MANAGEMENT | 615,546 | $9,793,000 | 1.05% |
| Penn Capital Management Company, LLC | 1,399,205 | $22,261,000 | 0.98% |
| Tamarack Advisers, LP | 450,000 | $7,160,000 | 0.94% |
| Piermont Capital Management Inc. | 139,020 | $2,212,000 | 0.70% |
| JW Asset Management, LLC | 101,630 | $1,617,000 | 0.60% |
| SECTORAL ASSET MANAGEMENT INC | 810,362 | $12,893,000 | 0.55% |
| Glacier Peak Capital LLC | 50,000 | $796,000 | 0.51% |